Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Viguera, A. C. Articles by Baldessarini, R. J. Search for Related Content PubMed Citation Articles by Viguera, A. C. Articles by Baldessarini, R. J. Bipolar Disorder Lithium

Risk of Recurrence of Bipolar Disorder in Pregnant and Nonpregnant Women After Discontinuing Lithium Maintenance

OBJECTIVE: Pregnancy poses major challenges for the treatment of bipolar disorder, and information to guide clinical care remains very sparse. The authors sought to determine the illness recurrence risk for women with bipolar disorder who discontinue lithium maintenance during pregnancy. METHOD: The authors retrospectively compared recurrence rates and survival functions for 101 women with DSM-IV bipolar disorder (68 type I, 33 type II) during pregnancy and postpartum (N=42) or during equivalent periods (weeks 1–40 and 41–64) for age-matched nonpregnant subjects (N=59) after either rapid (1–14 days) or gradual (15–30 days) discontinuation of lithium. Recurrence rates also were obtained for the year before discontinuing lithium. RESULTS: Rates of recurrence during the first 40 weeks after lithium discontinuation were similar for pregnant (52%) and nonpregnant women (58%) but had been much lower for both in the year before treatment was discontinued (21%). Among subjects who remained stable over the first 40 weeks after lithium discontinuation, postpartum recurrences were 2.9 times more frequent than recurrences in nonpregnant women during weeks 41–64 (70% versus 24%). Depressive or dysphoric-mixed episodes were more prevalent in pregnant than nonpregnant women (63% versus 38% of recurrences). Recurrence risk was greater after rapid than after gradual discontinuation, and for patients with more prior affective episodes, but was similar for diagnostic types I and II. CONCLUSIONS: Rates of recurrence during the first 40 weeks after lithium discontinuation were similar for pregnant and nonpregnant women but then sharply increased postpartum. Risk was much lower during preceding treatment and less with gradual discontinuation. Treatment planning for potentially pregnant women with bipolar disorder should consider the relative risks of fetal exposure to mood stabilizers versus the high recurrence risks after discontinuing lithium.

This article has been cited by other articles:

				A. C. VIGUERA, Dr. Viguera Replies Am J Psychiatry, May 1, 2008; 165(5): 647 - 648. [Full Text] [PDF]

				M. P. Freeman Bipolar Disorder and Pregnancy: Risks Revealed Am J Psychiatry, December 1, 2007; 164(12): 1771 - 1773. [Full Text] [PDF]

				A. C. Viguera, T. Whitfield, R. J. Baldessarini, D. J. Newport, Z. Stowe, A. Reminick, A. Zurick, and L. S. Cohen Risk of Recurrence in Women With Bipolar Disorder During Pregnancy: Prospective Study of Mood Stabilizer Discontinuation Am J Psychiatry, December 1, 2007; 164(12): 1817 - 1824. [Abstract] [Full Text] [PDF]

				K. L. Wisner, C. Chambers, and D. K. Y. Sit Postpartum Depression: A Major Public Health Problem JAMA, December 6, 2006; 296(21): 2616 - 2618. [Full Text] [PDF]

				T. Terao Antidepressant treatment and relapse of depression during pregnancy. JAMA, July 12, 2006; 296(2): 165 - 165. [Full Text] [PDF]

				L. S. Cohen, R. Nonacs, A. C. Viguera, A. M. Reminick, L. L. Altshuler, R. Suri, V. K. Burt, V. Hendrick, B. L. Harlow, A. F. Vitonis, et al. Antidepressant Treatment and Relapse of Depression During Pregnancy--Reply JAMA, July 12, 2006; 296(2): 166 - 167. [Full Text] [PDF]

				C. L. Devane, Z. N. Stowe, J. L. Donovan, D. J. Newport, P. B. Pennell, J. C. Ritchie, M. J. Owens, and J.-S. Wang Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities. J Psychopharmacol, July 1, 2006; 20(4 Suppl): 54 - 59. [Abstract] [PDF]

				D. J. Newport, A. C. Viguera, A. J. Beach, J. C. Ritchie, L. S. Cohen, and Z. N. Stowe Lithium Placental Passage and Obstetrical Outcome: Implications for Clinical Management During Late Pregnancy Am J Psychiatry, November 1, 2005; 162(11): 2162 - 2170. [Abstract] [Full Text] [PDF]

				K. A. Yonkers, K. L. Wisner, Z. Stowe, E. Leibenluft, L. Cohen, L. Miller, R. Manber, A. Viguera, T. Suppes, and L. Altshuler Management of Bipolar Disorder During Pregnancy The Postpartum Period Focus, April 1, 2005; 3(2): 266 - 279. [Abstract] [Full Text] [PDF]

				S. Gentile Clinical Utilization of Atypical Antipsychotics in Pregnancy and Lactation Ann. Pharmacother., July 1, 2004; 38(7): 1265 - 1271. [Abstract] [Full Text] [PDF]

				K. A. Yonkers, K. L. Wisner, Z. Stowe, E. Leibenluft, L. Cohen, L. Miller, R. Manber, A. Viguera, T. Suppes, and L. Altshuler Management of Bipolar Disorder During Pregnancy and the Postpartum Period Am J Psychiatry, April 1, 2004; 161(4): 608 - 620. [Abstract] [Full Text] [PDF]

				L. G. Costa, L. Steardo, and V. Cuomo Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects Pharmacol. Rev., March 1, 2004; 56(1): 103 - 147. [Abstract] [Full Text] [PDF]

				D. Kohen Psychotropic medication in pregnancy Advan. Psychiatr. Treat., January 1, 2004; 10(1): 59 - 66. [Abstract] [Full Text] [PDF]

				D. L. Dell and B. W. O'Brien Suicide in Pregnancy Obstet. Gynecol., December 1, 2003; 102(6): 1306 - 1309. [Abstract] [Full Text] [PDF]

				R. M.A. Hirschfeld, C. L. Bowden, M. J. Gitlin, P. E. Keck, R. H. Perlis, T. Suppes, M. E. Thase, and K. D. Wagner Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision) Focus, January 1, 2003; 1(1): 64 - 110. [Full Text] [PDF]

				A. C. Viguera, L. S. Cohen, S. Bouffard, T. H. Whitfield, and R. J. Baldessarini Reproductive Decisions by Women With Bipolar Disorder After Prepregnancy Psychiatric Consultation Am J Psychiatry, December 1, 2002; 159(12): 2102 - 2104. [Abstract] [Full Text] [PDF]

				R. H. Perlis, G. S. Sachs, B. Lafer, M. W. Otto, S. V. Faraone, J. M. Kane, and J. F. Rosenbaum Effect of Abrupt Change From Standard to Low Serum Levels of Lithium: A Reanalysis of Double-Blind Lithium Maintenance Data Am J Psychiatry, July 1, 2002; 159(7): 1155 - 1159. [Abstract] [Full Text] [PDF]

				A. RIFKIN Lithium discontinuation during pregnancy. Am J Psychiatry, October 1, 2001; 158(10): 1741 - 1742. [Full Text] [PDF]

				V. K. Burt, R. Suri, L. Altshuler, Z. Stowe, V. C. Hendrick, and E. Muntean The Use of Psychotropic Medications During Breast-Feeding Am J Psychiatry, July 1, 2001; 158(7): 1001 - 1009. [Abstract] [Full Text]

				Should Lithium Be Used During Pregnancy? Journal Watch Women's Health, April 1, 2000; 2000(401): 8 - 8. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us